Gene · 8817
Papers1,397
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,397
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Production of a risk mitigation matrix and four-grade threshold scale using Cox Regression to predict osteoarthritis development. | Open Life Sci | 2026 | 41726568 | PubTator, text mining | PubMed |
| Identification of Chondrocyte Stemness-Associated Biomarkers in Osteoarthritis Using Bioinformatics and Machine Learning Approaches. | J Inflamm Res | 2026 | 41709967 | PubTator, text mining | PubMed |
| Whole-genome sequencing analysis of anthropometric traits in 672,976 individuals reveals convergence between rare and common genetic associations. | Nat Commun | 2026 | 41651857 | PubTator, text mining | PubMed |
| Integrated Analyses Identify CDH2 as a Hub Gene Associated with Cisplatin Resistance and Prognosis in Ovarian Cancer. | Int J Mol Sci | 2026 | 41596365 | PubTator, text mining | PubMed |
| Extracellular vesicles derived from adipose-derived mesenchymal stem/stromal cells prevent synovial inflammation and attenuate cartilage degeneration in rodent osteoarthritis. | Regen Ther | 2026 | 41551961 | PubTator, text mining | PubMed |
| Mitochondria dysfunction and increased expression of WNT5A and BNIP3 in tenocytes obtained from patients with tendinopathy. | JSES Int | 2026 | 41550705 | PubTator, text mining | PubMed |
| Bioinspired scaffold recapitulating chondrogenic ontogeny and microenvironment for functional cartilage regeneration. | Bioact Mater | 2026 | 41502980 | PubTator, text mining | PubMed |
| Pathology and Therapeutic Significance of Fibroblast Growth Factors. | Targets (Basel) | 2025 | 41743400 | PubTator, text mining | PubMed |
| Targeted therapy for liver cancer: Current status and future directions. | Bioimpacts | 2025 | 41716515 | PubTator, text mining | PubMed |
| Signaling of Mitogenic and Metabolic Activities by Fibroblast Growth Factors. | J Cell Signal | 2025 | 41394119 | PubTator, text mining | PubMed |
| Super-silencers are crucial for development and carcinogenesis in B cells. | Nat Commun | 2025 | 40998810 | PubTator, text mining | PubMed |
| The m6A modification in cancer: roles, implications, and its potential in therapy. | Mol Biomed | 2025 | 40986143 | PubTator, text mining | PubMed |
| Transgenerational inheritance of diminished ovarian reserve triggered by prenatal propylparaben exposure in mice. | Nat Commun | 2025 | 40957879 | PubTator, text mining | PubMed |
| Exploring the potential role of fibroblast growth factors in alleviating hepatic ischemia-reperfusion injury: From in vitro insights to clinical investigations. | Eur J Pharmacol | 2025 | 40876610 | PubTator, text mining | PubMed |
| Fibroblast Growth Factors in Lung Development and Regeneration: Mechanisms and Therapeutic Potential. | Cells | 2025 | 40862735 | PubTator, text mining | PubMed |
| Identification and validation of ECM1 as a causal plasma biomarker in knee osteoarthritis through proteome-wide association study and bioinformatics. | Medicine (Baltimore) | 2025 | 40859530 | PubTator, text mining | PubMed |
| Regulation of feather length: FGF/IGF signaling and NOTCH/YAP modulation of progenitor cell topology. | Sci Adv | 2025 | 40845092 | PubTator, text mining | PubMed |
| Meta-Analysis of Gene Expression Reveals the Core Transcriptomic Profile of Lesional Scalp in Alopecia Areata. | Dermatol Ther (Heidelb) | 2025 | 40748556 | PubTator, text mining | PubMed |
| Application of gene therapy in osteoarthritis. | Connect Tissue Res | 2025 | 40717471 | PubTator, text mining | PubMed |
| Dual-functional ROS-responsive hydrogel alleviates temporomandibular joint osteoarthritis by enhancing cartilage repair and mitigating inflammation. | Mater Today Bio | 2025 | 40704013 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8817/papers?page=2